ANALYTICAL NEBULIZER MARKET REPORT OVERVIEW
-
Request a Free Sample to learn more about this report
The global analytical nebulizer market size was USD 21 million in 2020 and the market is projected to touch USD 32 million by 2027, exhibiting a CAGR of 6.7% during the forecast period.
A nebulizer is a type of medical device used to turn medicine into sprays and deliver it directly to the lungs. It is mostly used to treat lung diseases such as asthma, cystic fibrosis and COPD. Increasing prevalence of chronic respiratory diseases is boosting the growth of the nebulizer market.
The rapid growth is due to an increase in chronic respiratory diseases, increasing demand for home medical equipment and a growing elderly population. Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the United States, according to the Centers for Disease Control and Prevention. In addition, the increase in consumption of alcohol, tobacco and ultra-processed products, including sugar-sweetened beverages others are the leading cause of increased respiratory disease in North America. Thus, the increase in the number of smokers and environmental pollution is expected to increase the demand for nebulizers.
COVID-19 Impact: Market Growth Restrained by Pandemic due to Supply Chain Disruptions
The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.
The COVID-19 pandemic is expected to have a major impact on the market. Albuterol inhalers are more commonly used in hospitals to help patients with respiratory problems with COVID-19 and suspected COVID-19. This is mainly because respiratory viruses are the most common cause of asthma complications and nebulizers can help with relief. In addition, the elderly are more susceptible to respiratory diseases such as chronic obstructive pulmonary disease (COPD), sleep apnea and COVID-19 due to various factors, such as a gradual decline in immune function.
LATEST TRENDS
"Jet Nebulizers Segment Will Hold A Major Share During The Forecast Period"
A nebulizer turns medicine from a liquid into a mist. Jet nebulizers use compressed gas to produce an aerosol (small medicine particles in the air). A spray nebulizer is a machine that turns liquid medicine into a fine mist that the patient can inhale through a face mask or mouthpiece. The greatest advantage of showers is their efficiency and only the requirement of simple, tidal breathing. In addition, dose conversion and dose combining are possible in nebulizers.
ANALYTICAL NEBULIZER MARKET SEGMENTATION
-
Request a Free Sample to learn more about this report
- By Type
Based on type the global market can be categorized into Induction Nebulizers, Non-Induction Nebulizers.
Induction nebulizer is used to collect an adequate sample of lower respiratory secretions in individuals who do not produce sputum.
A non-induction nebulizer is a new type of nebulizer that does not use induction to mix the sample and gas. Instead, pneumatic atomization is used here, resulting in micro mixing of fluids with a recirculation element
- By Application
Based on application the global market can be categorized into Pharmaceutical and Clinical Study, Biological, Environmental and Agricultural Assessment, Petroleum Testing, Others.
For pharmaceutical and clinical research, nebulizers are particularly good for babies and for young children and asthma medications. They are also helpful if you have difficulty using an asthma inhaler or need a large dose of inhaled medication.
Analytical nebulizers are used in trace element analysis and isolation of any element. This type of work plays an important role in pharmaceutical and clinical research, biological, environmental and agricultural assessment, and oil testing.
DRIVING FACTORS
"Increasing The Population Is Aging And Technological Progress to Accelerate Market Growth"
A nebulizer facilitates the delivery of medicines to the lungs in the form of a mist. Increasing prevalence of respiratory diseases such as chronic obstructive pulmonary disease, asthma and cystic fibrosis is a major factor driving the demand for nebulizers worldwide. Increasing investments and developments in drug delivery devices have contributed to the growth of the global nebulizer market. Growing elderly population and increasing incidence of respiratory diseases are increasing the demand for nebulizers. Growing demand for home healthcare devices and aging population is expected to drive the growth of the nebulizer market during the forecast period. The nebulizer market is expected to continue to grow as a result of technological advancements. On the other hand, the decline in the number of nebulized drugs is expected to boost the analytical nebulizer market growth during the forecast period.
"Increasing Prevalence of Respiratory Disorders to Fuel the Market growth"
One of the key factors driving analytical nebulizer market growth is the increasing prevalence of respiratory disorders. They are used as drug delivery devices used to control the symptoms and progression of cystic fibrosis, COPDs, asthma, and other respiratory diseases. Asthma is a common non-communicable disease, which has a substantial impact on the quality of life. It is also considered one of the most common causes of disabled years. The increasing incidence of asthma is increasing the demand for nebulizers and fueling the market growth during the forecast period. COPD is also a serious respiratory disease and one of the leading causes of death worldwide. The high prevalence of COPD increases the demand for nebulizers, as the sprayed water vapor changes the viscosity of the mucus and helps with coughing. Air-powered nebulizers are often used to treat acute exacerbations and COPD. In addition, nebulizers are used to prevent pneumonia in patients with HIV antibodies, which increases the demand for nebulizers.
RESTRAINING FACTORS
"Risk Of Transmission Of Infection to Impede Market Growth"
The safety profile of respirators in terms of the spread of infection has raised concerns. Factors such as the risk of transmission of infection from the nebulizer tube to the patient and into the lungs, or transmission of infection from unsterile rooms of the devices, further limit the recommendations of health professionals on the use of these devices. Cost and increasing availability of alternative treatment options are also limiting the growth of the segment. Demand for nebulizers is likely to face competition as patients increasingly accept replacement devices to treat respiratory ailments. Their health care providers increasingly prefer inhalers, including metered-dose inhalers used to treat asthma. The clinical and functional advantages of MDIs in the treatment of asthma and the lower cost of these devices have shown that patients prefer to switch from nebulizers to inhalers. In addition, the limited compensation policy in developing economies and the higher costs of networks nebulizers are likely to hinder the growth of the nebulizer market during the forecast period.
ANALYTICAL NEBULIZER MARKET REGIONAL INSIGHTS
-
Request a Free Sample to learn more about this report
"North America to Dominate the Market due to Technological Advancements "
The market is primarily segregated into Europe, Latin America, Asia Pacific, North America, and Middle East & Africa.
North America dominates the analytical nebulizer market share due to technological advancements and product launches. Additionally, the prevalence of respiratory diseases will drive the growth of the region and nebulizer market during the forecast period. The nebulizer market in Asia Pacific is expected to grow significantly due to aging population and emphasis on preventive maintenance. In addition, support for technological innovations and government initiatives and increasing usage of ventilators in post-operative rooms, delivery rooms, and nursing offices are expected to help drive the growth of the nebulizer market in the region in the coming years.
KEY INDUSTRY PLAYERS
"Key Industry Players Shaping the Market through Innovation and Market Expansion"
Key market players in the global nebulizer market are constantly engaged in various development strategies such as product launches, collaborations, and partnerships to enhance their market supremacy and gain a competitive edge over others. These development strategies are expected to provide new growth prospects and stimulate the growth of the global nebulizer market in the coming future. The collective efforts of these major players significantly impact the competitive landscape and future trajectory of the market.
List of Market Players Profiled
- Glass Expansion (Australia)
- Burgener (Switzerland)
- Precision Glassblowing (U.S.)
- Savillex (U.S.)
- Meinhard (Singapore)
INDUSTRIAL DEVELOPMENT
December 2020: AireHealth has received US FDA approval for its connected electronic nebulizer.
REPORT COVERAGE
The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.
The research report delves into market segmentation, utilizing both qualitative and quantitative research methods to provide a thorough analysis. It also evaluates the impact of financial and strategic perspectives on the market. Furthermore, the report presents national and regional assessments, considering the dominant forces of supply and demand that influence market growth. The competitive landscape is meticulously detailed, including market shares of significant competitors. The report incorporates novel research methodologies and player strategies tailored for the anticipated timeframe. Overall, it offers valuable and comprehensive insights into the market dynamics in a formal and easily understandable manner.
REPORT COVERAGE | DETAILS |
---|---|
Market Size Value In |
US$ 21 Million in 2020 |
Market Size Value By |
US$ 32 Million by 2027 |
Growth Rate |
CAGR of 6.7% from 2020 to 2027 |
Forecast Period |
2022-2027 |
Base Year |
2023 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered |
Types & Application |
Frequently Asked Questions
-
What value is the analytical nebulizer market expected to touch by 2027?
The global analytical nebulizer market is expected to reach USD 32 million by 2027.
-
What CAGR is the analytical nebulizer market expected to exhibit by 2027?
The analytical nebulizer market is expected to exhibit a CAGR of 6.7% by 2027.
-
Which are the driving factors of the analytical nebulizer market?
Increasing the population is aging and technological progress and increasing prevalence of respiratory disorders are some of the driving factors of the analytical nebulizer market.
-
What are the key analytical nebulizer market segments?
The analytical nebulizer market segmentation that you should be aware of, which include, Based on type the analytical nebulizer market is classified as Induction Nebulizers, Non-Induction Nebulizers. Based on application the analytical nebulizer market is classified as Pharmaceutical and Clinical Study, Biological, Environmental and Agricultural Assessment, Petroleum Testing, Others.